Enzalutamide – March 2021

• Brand names:
  • Xtandi®
• Pharmaceutical Company:
  • Astellas Pharma Australia Pty Ltd
• Condition/Indication: Metastatic prostate cancer
• Meeting Date: March 2021
• Public Summary Document (PSD) March 2021 PBAC Meeting - (PDF 860KB)
• Public Summary Document (PSD) March 2021 PBAC Meeting - (Word 55KB)

Related Public Summary Documents

• Abiraterone acetate – March 2021